Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (369)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
47
2024
372
8.170
 Why?
Multiple Sclerosis, Relapsing-Remitting
14
2024
69
3.040
 Why?
Neurology
10
2018
85
2.430
 Why?
Immunosuppressive Agents
10
2024
641
1.780
 Why?
Immunologic Factors
11
2020
217
1.670
 Why?
Neuromyelitis Optica
4
2023
115
1.220
 Why?
Natalizumab
11
2021
46
0.980
 Why?
Recurrence
7
2024
925
0.780
 Why?
Diagnostic Errors
2
2017
150
0.760
 Why?
Internship and Residency
5
2011
920
0.750
 Why?
Drug Substitution
2
2019
46
0.680
 Why?
Fingolimod Hydrochloride
5
2020
29
0.670
 Why?
Rituximab
4
2020
148
0.640
 Why?
Brain
14
2021
2355
0.640
 Why?
Data Collection
4
2011
618
0.630
 Why?
Dementia, Vascular
3
2009
16
0.610
 Why?
Drug Monitoring
1
2019
184
0.590
 Why?
Medication Adherence
2
2019
531
0.550
 Why?
Early Medical Intervention
1
2017
52
0.550
 Why?
Early Diagnosis
2
2017
217
0.540
 Why?
Physicians
4
2016
765
0.530
 Why?
Glatiramer Acetate
6
2019
20
0.520
 Why?
Calcinosis
2
2009
239
0.500
 Why?
Antibodies, Monoclonal, Humanized
8
2023
660
0.500
 Why?
Postural Balance
3
2018
185
0.490
 Why?
Humans
79
2024
114043
0.490
 Why?
Magnetic Resonance Imaging
23
2023
3039
0.470
 Why?
Fatigue
3
2018
294
0.420
 Why?
Dimethyl Fumarate
3
2020
10
0.390
 Why?
Immunoglobulin G
4
2023
766
0.380
 Why?
Practice Guidelines as Topic
1
2018
1381
0.360
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
25
0.340
 Why?
Withholding Treatment
2
2021
66
0.340
 Why?
Middle Aged
37
2021
26605
0.330
 Why?
Psychiatry
2
2009
154
0.320
 Why?
Adult
41
2023
30375
0.310
 Why?
Cysts
1
2009
92
0.300
 Why?
Demyelinating Diseases
4
2019
73
0.300
 Why?
Education, Medical
1
2011
214
0.300
 Why?
Certification
1
2008
84
0.290
 Why?
Autoantibodies
3
2023
1347
0.290
 Why?
Clinical Trials as Topic
3
2016
926
0.280
 Why?
Education
2
2007
93
0.280
 Why?
Central Nervous System Cysts
1
2006
10
0.270
 Why?
Cerebral Arteries
1
2006
55
0.260
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
44
0.260
 Why?
Single-Blind Method
3
2023
259
0.260
 Why?
Societies, Medical
4
2019
655
0.260
 Why?
Cerebrovascular Disorders
1
2006
82
0.260
 Why?
Treatment Outcome
12
2023
9049
0.260
 Why?
Female
46
2023
59325
0.260
 Why?
DNA, Viral
2
1998
349
0.250
 Why?
HIV Long Terminal Repeat
2
1997
8
0.250
 Why?
Databases, Factual
3
2016
1125
0.250
 Why?
Male
36
2023
55396
0.240
 Why?
Double-Blind Method
4
2023
1656
0.230
 Why?
Drug Industry
2
2016
103
0.230
 Why?
Conflict of Interest
2
2016
119
0.220
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
47
0.210
 Why?
Quality of Health Care
2
2017
572
0.200
 Why?
Mental Disorders
2
2007
889
0.200
 Why?
B-Lymphocytes
5
2023
762
0.200
 Why?
Brain Neoplasms
4
2016
966
0.200
 Why?
Lymphoma
2
2005
176
0.190
 Why?
Interferon beta-1a
2
2019
12
0.190
 Why?
Neuroimaging
1
2023
249
0.180
 Why?
Central Nervous System Neoplasms
2
2005
125
0.180
 Why?
Education, Medical, Continuing
2
2015
115
0.180
 Why?
Disease Progression
4
2021
2371
0.180
 Why?
Lymphopenia
1
2020
49
0.170
 Why?
Agammaglobulinemia
1
2020
30
0.170
 Why?
Referral and Consultation
1
2005
632
0.170
 Why?
Interferon-gamma
1
2023
719
0.170
 Why?
Neutropenia
1
2020
123
0.170
 Why?
Serum Sickness
1
2019
7
0.170
 Why?
Indans
1
2019
9
0.170
 Why?
Oxadiazoles
1
2019
32
0.170
 Why?
Diagnosis, Differential
4
2023
1331
0.160
 Why?
Educational Measurement
3
2015
235
0.150
 Why?
Adjuvants, Immunologic
3
2015
206
0.150
 Why?
Salvage Therapy
1
2019
127
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.150
 Why?
Physician-Patient Relations
2
2016
459
0.150
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
519
0.150
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
239
0.150
 Why?
Herpesvirus 8, Human
1
1998
61
0.140
 Why?
Eye Movements
1
2018
51
0.140
 Why?
Central Nervous System
2
2005
230
0.140
 Why?
AIDS Dementia Complex
1
1997
50
0.140
 Why?
Patient Selection
2
2015
629
0.140
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.140
 Why?
Sarcoma, Kaposi
1
1998
68
0.140
 Why?
Herpesvirus 4, Human
1
2018
124
0.140
 Why?
HIV Seropositivity
1
1998
109
0.140
 Why?
Young Adult
6
2023
10444
0.140
 Why?
Neurologists
1
2016
18
0.130
 Why?
Herpesviridae Infections
1
1998
138
0.130
 Why?
Aged
8
2023
18969
0.130
 Why?
Cost-Benefit Analysis
2
2016
544
0.130
 Why?
Costs and Cost Analysis
1
2017
196
0.130
 Why?
Estriol
1
2015
5
0.130
 Why?
T-Lymphocytes
1
2023
1735
0.130
 Why?
Dizziness
2
2018
70
0.130
 Why?
Verbal Learning
2
2013
63
0.120
 Why?
Corpus Callosum
2
2006
56
0.120
 Why?
Follow-Up Studies
6
2020
4392
0.120
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
83
0.120
 Why?
Retrospective Studies
9
2020
12521
0.120
 Why?
Trust
1
2016
103
0.120
 Why?
Ethics, Medical
1
2015
69
0.120
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
37
0.110
 Why?
Exercise Therapy
1
2018
351
0.110
 Why?
Insurance, Health
1
2016
243
0.110
 Why?
Medication Reconciliation
1
2013
25
0.110
 Why?
CD40 Antigens
1
2014
81
0.110
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
127
0.110
 Why?
Anti-Inflammatory Agents
2
2006
445
0.110
 Why?
JC Virus
1
2013
23
0.110
 Why?
Population Surveillance
1
2016
385
0.100
 Why?
Glioma
1
2016
285
0.100
 Why?
Sensation Disorders
1
2012
31
0.100
 Why?
Memory Disorders
1
2013
153
0.100
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.100
 Why?
Immunoglobulin Heavy Chains
3
2007
72
0.100
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.100
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
15
0.100
 Why?
Optic Nerve
2
2005
65
0.100
 Why?
T-Lymphocyte Subsets
1
2014
383
0.100
 Why?
Quality of Life
3
2021
2343
0.090
 Why?
Gadolinium
4
2018
73
0.090
 Why?
Learning
1
2015
346
0.090
 Why?
Biomarkers
3
2014
3397
0.090
 Why?
Self-Assessment
1
2011
60
0.090
 Why?
Academies and Institutes
1
2011
44
0.090
 Why?
Nervous System Diseases
1
2013
254
0.090
 Why?
Nerve Regeneration
1
2010
50
0.090
 Why?
Fatal Outcome
3
2006
281
0.090
 Why?
Diagnostic Tests, Routine
1
2011
87
0.090
 Why?
Antigens, CD19
3
2007
91
0.090
 Why?
Severity of Illness Index
3
2014
2537
0.090
 Why?
Leukocytosis
1
2010
34
0.090
 Why?
Exercise Test
1
2012
547
0.090
 Why?
Cranial Nerve Neoplasms
1
1989
6
0.080
 Why?
Hemangioma, Cavernous
1
1989
14
0.080
 Why?
United States
7
2019
12137
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Disease Management
1
2013
556
0.080
 Why?
Central Nervous System Infections
1
2010
36
0.080
 Why?
Guidelines as Topic
1
2011
241
0.080
 Why?
Spinal Cord
3
2023
344
0.080
 Why?
Physical Therapy Modalities
1
2011
265
0.080
 Why?
Neuroprotective Agents
1
2009
102
0.080
 Why?
Practice Patterns, Physicians'
1
2016
1175
0.080
 Why?
Workload
1
2009
131
0.070
 Why?
Antibodies, Monoclonal
2
2011
1257
0.070
 Why?
Hospital-Physician Relations
1
2007
2
0.070
 Why?
Neuropsychological Tests
2
2013
926
0.070
 Why?
Immunoglobulin Variable Region
2
2004
72
0.070
 Why?
HIV-1
1
1992
768
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
16
0.070
 Why?
Headache Disorders
1
2006
12
0.070
 Why?
Nerve Fibers, Myelinated
1
2006
41
0.070
 Why?
Huntington Disease
1
2007
40
0.070
 Why?
Contrast Media
3
2018
347
0.070
 Why?
Medical Records
1
2007
153
0.070
 Why?
Glial Fibrillary Acidic Protein
1
2006
79
0.070
 Why?
Syndrome
2
2023
330
0.070
 Why?
International Classification of Diseases
1
2007
116
0.070
 Why?
Methylprednisolone
1
2006
80
0.070
 Why?
Antibody Formation
1
2007
266
0.070
 Why?
Intracranial Hemorrhages
1
2006
76
0.070
 Why?
Fellowships and Scholarships
1
2009
224
0.060
 Why?
Herpes Zoster
1
2010
330
0.060
 Why?
Surveys and Questionnaires
4
2016
4595
0.060
 Why?
Aquaporin 4
1
2006
86
0.060
 Why?
Canada
2
2019
320
0.060
 Why?
DNA Mutational Analysis
1
2006
373
0.060
 Why?
RNA, Messenger
1
1992
2550
0.060
 Why?
Erythrocytes
1
2010
568
0.060
 Why?
Patient Compliance
1
2009
524
0.060
 Why?
Health Care Surveys
1
2007
541
0.060
 Why?
Teaching
1
2007
209
0.060
 Why?
Neutrophils
1
2010
1089
0.060
 Why?
Cognition Disorders
1
2009
476
0.060
 Why?
Analysis of Variance
3
2015
1218
0.060
 Why?
Affect
1
2007
246
0.060
 Why?
Neurologic Examination
1
2005
113
0.060
 Why?
Program Evaluation
1
2009
820
0.060
 Why?
Central Nervous System Diseases
1
2005
60
0.060
 Why?
Faculty, Medical
1
2006
226
0.060
 Why?
Simvastatin
1
2004
58
0.060
 Why?
Ophthalmoplegia
1
2003
8
0.060
 Why?
Proteoglycans
1
2004
107
0.060
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
35
0.050
 Why?
Adolescent
7
2021
17800
0.050
 Why?
B-Lymphocyte Subsets
1
2003
68
0.050
 Why?
Cyclophosphamide
1
2003
214
0.050
 Why?
Students, Medical
1
2006
262
0.050
 Why?
Anticoagulants
1
2006
547
0.050
 Why?
Radiography
1
2005
803
0.050
 Why?
Cross-Sectional Studies
1
2012
4402
0.050
 Why?
Academic Medical Centers
1
2005
405
0.050
 Why?
Dementia
1
2005
186
0.050
 Why?
Membrane Glycoproteins
1
2004
429
0.050
 Why?
Infusions, Intravenous
1
2023
370
0.050
 Why?
Clinical Competence
1
2008
882
0.050
 Why?
Patient Outcome Assessment
1
2023
122
0.050
 Why?
Lymphoma, B-Cell
2
2005
87
0.050
 Why?
Peptides
3
2013
848
0.050
 Why?
Time Factors
4
2018
6077
0.050
 Why?
Pain
1
2007
701
0.050
 Why?
Schools, Medical
1
2002
121
0.050
 Why?
Disability Evaluation
2
2014
271
0.050
 Why?
Molecular Sequence Data
3
2004
2783
0.050
 Why?
Consensus
1
2023
532
0.050
 Why?
Antibodies, Antinuclear
1
2001
58
0.050
 Why?
Child
5
2016
18400
0.050
 Why?
Atrophy
1
2021
152
0.050
 Why?
Antibodies, Viral
1
2023
520
0.040
 Why?
Mobility Limitation
1
2020
60
0.040
 Why?
Lipids
1
2023
564
0.040
 Why?
Interferon-beta
2
2011
79
0.040
 Why?
Lymphocyte Activation
1
2003
1036
0.040
 Why?
Maintenance Chemotherapy
1
2019
22
0.040
 Why?
Induction Chemotherapy
1
2019
56
0.040
 Why?
Cerebral Infarction
1
1998
39
0.040
 Why?
Cell Separation
2
2014
290
0.040
 Why?
Transplantation, Autologous
1
2019
175
0.040
 Why?
HIV Seronegativity
1
1998
24
0.040
 Why?
Genes, myc
1
1998
46
0.040
 Why?
Astrocytoma
1
1998
106
0.040
 Why?
Risk Assessment
1
2006
2958
0.040
 Why?
In Situ Hybridization
1
2018
292
0.040
 Why?
Gene Library
1
1997
114
0.040
 Why?
Breast Neoplasms
1
2008
1846
0.040
 Why?
Gene Rearrangement
1
1998
135
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
314
0.030
 Why?
Mutation
1
2006
3338
0.030
 Why?
Syndecan-1
2
2007
27
0.030
 Why?
Viral Load
1
2018
405
0.030
 Why?
Flow Cytometry
2
2014
1075
0.030
 Why?
Drug Administration Schedule
1
2018
714
0.030
 Why?
Colorado
1
2005
4090
0.030
 Why?
Child, Preschool
3
2016
9114
0.030
 Why?
Polymerase Chain Reaction
1
1998
990
0.030
 Why?
Survival Analysis
1
2018
1206
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1168
0.030
 Why?
Sequence Analysis, DNA
1
1997
722
0.030
 Why?
Patient Care Team
1
2019
517
0.030
 Why?
Incidence
1
2020
2314
0.030
 Why?
Base Sequence
1
1997
2114
0.030
 Why?
Congresses as Topic
1
2015
193
0.030
 Why?
Propylene Glycols
1
2013
25
0.030
 Why?
Ocular Physiological Phenomena
1
1992
11
0.030
 Why?
Sphingosine
1
2013
33
0.030
 Why?
HLA-DR Antigens
1
2014
219
0.030
 Why?
Mice
2
2023
14841
0.030
 Why?
Drug Therapy, Combination
1
2015
949
0.030
 Why?
beta-Galactosidase
1
1992
62
0.030
 Why?
Quality-Adjusted Life Years
1
2013
103
0.030
 Why?
Markov Chains
1
2013
114
0.030
 Why?
Animals
3
2023
31565
0.030
 Why?
Mice, Inbred DBA
1
1992
174
0.030
 Why?
Haplotypes
1
2014
448
0.030
 Why?
Mental Recall
1
2013
171
0.020
 Why?
Comparative Effectiveness Research
1
2013
131
0.020
 Why?
Depression
2
2011
1133
0.020
 Why?
Organ Specificity
1
1992
266
0.020
 Why?
Reference Values
1
2013
739
0.020
 Why?
Intestine, Small
1
1992
121
0.020
 Why?
CD3 Complex
1
2012
92
0.020
 Why?
Ki-67 Antigen
1
2012
102
0.020
 Why?
Thymus Gland
1
1992
296
0.020
 Why?
Patient Participation
1
2015
348
0.020
 Why?
Mitoxantrone
1
2011
12
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Muscle Stretching Exercises
1
2011
17
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1204
0.020
 Why?
Aged, 80 and over
2
2016
6306
0.020
 Why?
Clinical Laboratory Techniques
1
2011
86
0.020
 Why?
Recombinant Fusion Proteins
1
1992
613
0.020
 Why?
Physical Endurance
1
2011
232
0.020
 Why?
Amino Acid Sequence
2
2004
1981
0.020
 Why?
Prevalence
1
2016
2247
0.020
 Why?
Spinal Cord Neoplasms
1
1989
36
0.020
 Why?
Respiratory Function Tests
1
2011
522
0.020
 Why?
Acyclovir
1
2010
100
0.020
 Why?
Cell Count
1
2010
303
0.020
 Why?
Pilot Projects
2
2004
1360
0.020
 Why?
History, 19th Century
1
2009
54
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
52
0.020
 Why?
Injections
1
2009
160
0.020
 Why?
History, 21st Century
1
2009
160
0.020
 Why?
Autoimmunity
1
2014
812
0.020
 Why?
Electrocardiography
1
2011
561
0.020
 Why?
History, 20th Century
1
2009
265
0.020
 Why?
Mice, Transgenic
1
1992
1947
0.020
 Why?
Gene Expression
1
1992
1417
0.020
 Why?
Age of Onset
1
2009
444
0.020
 Why?
Memory
1
2009
209
0.020
 Why?
Walking
1
2011
422
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
686
0.020
 Why?
Health
1
2007
74
0.020
 Why?
Prognosis
2
2006
3315
0.020
 Why?
Association Learning
1
2007
60
0.020
 Why?
Cerebral Ventricles
1
2006
47
0.020
 Why?
Phenotype
1
2014
2784
0.020
 Why?
Hospitalization
1
2015
1762
0.020
 Why?
Motor Skills
1
2007
82
0.020
 Why?
Herpesvirus 3, Human
1
2010
377
0.020
 Why?
Immunologic Memory
1
2007
313
0.020
 Why?
Hypothalamus
1
2006
147
0.020
 Why?
Social Support
1
2009
528
0.020
 Why?
Genetics
1
2005
27
0.020
 Why?
Models, Theoretical
1
2009
513
0.020
 Why?
Neurosciences
1
2005
20
0.020
 Why?
Internet
1
2009
591
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
224
0.010
 Why?
Clinical Protocols
1
2006
232
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Risk Factors
2
2008
8614
0.010
 Why?
Anisotropy
1
2004
61
0.010
 Why?
Antiviral Agents
1
2010
642
0.010
 Why?
Immune System
1
2005
171
0.010
 Why?
Plasma Cells
1
2004
56
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
12
0.010
 Why?
Feasibility Studies
1
2006
735
0.010
 Why?
Videotape Recording
1
2003
30
0.010
 Why?
Infrared Rays
1
2003
20
0.010
 Why?
Meningitis, Viral
1
2003
21
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
97
0.010
 Why?
Saccades
1
2003
35
0.010
 Why?
Mice, Inbred C57BL
1
1992
4680
0.010
 Why?
Astrocytes
1
2005
159
0.010
 Why?
Antilymphocyte Serum
1
2003
60
0.010
 Why?
Oligoclonal Bands
1
2003
21
0.010
 Why?
Microglia
1
2005
198
0.010
 Why?
Antigens, CD34
1
2003
88
0.010
 Why?
Clone Cells
1
2003
247
0.010
 Why?
Whole-Body Irradiation
1
2003
72
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
107
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2272
0.010
 Why?
Immunoglobulins
1
2003
143
0.010
 Why?
Observer Variation
1
2003
298
0.010
 Why?
Longitudinal Studies
1
2009
2384
0.010
 Why?
Sex Characteristics
1
2007
636
0.010
 Why?
Age Factors
1
2009
2885
0.010
 Why?
Infant
1
2015
7943
0.010
 Why?
Administration, Oral
1
2004
725
0.010
 Why?
Urinary Tract Infections
1
2003
131
0.010
 Why?
Cohort Studies
1
2011
4883
0.010
 Why?
Biopsy
1
2005
1024
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
924
0.010
 Why?
Predictive Value of Tests
1
2006
1791
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
18
0.010
 Why?
Cytomegalovirus Infections
1
2003
180
0.010
 Why?
Acute Disease
1
2003
907
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
69
0.010
 Why?
Lung
1
1992
3521
0.010
 Why?
Research
1
2003
389
0.010
 Why?
Combined Modality Therapy
1
2003
1117
0.010
 Why?
Survival Rate
1
2003
1638
0.010
 Why?
Sensitivity and Specificity
1
2003
1690
0.010
 Why?
Arachnoid
1
1998
9
0.010
 Why?
Models, Biological
1
2005
1611
0.010
 Why?
Case-Control Studies
1
2004
3003
0.010
 Why?
Aging
1
2007
1611
0.010
 Why?
Reproducibility of Results
1
2003
2764
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (369) concept(s)
_
Co-Authors Expand Description
See all (34) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)